Key result
Bradykinin relaxes coronary arteries via EDHF and NO through large-conductance calcium-activated potassium channels.
Why the study?
It is controversial whether endothelium-dependent relaxation resistance to nitric oxide and prostacyclin synthase inhibitors is fully attributed to endothelium-derived hyperpolarizing factor in coronary arteries.
Does bradykinin induce endothelium-dependent relaxation and hyperpolarization in porcine coronary arteries resistant to L-NNA and indomethacin?
Population
Porcine coronary arteries including large arteries and microarteries
Comparison
Bradykinin-induced relaxation with and without inhibitors L-NNA, indomethacin, K+ channel blockers, and oxyhemoglobin
Design
Preclinical experimental study measuring NO release, isometric force, and membrane potential
Authors
Loading...
Does not support clinical translation; leaves open human in vivo validation of BKCa-mediated coronary relaxation.
Does bradykinin induce endothelium-dependent relaxation and hyperpolarization in porcine coronary arteries resistant to L-NNA and indomethacin?
Both EDHF and NO contribute to bradykinin-induced relaxation resistance to indomethacin and L-NNA in porcine coronary arteries, mediated primarily by large conductance Ca2+-activated K+ channels.
Zhen Ge (2000) studied this question. Bradykinin was evaluated on NO release, isometric force, and membrane potential. In porcine coronary arteries, both EDHF and NO contribute to bradykinin-induced relaxation resistance to indomethacin and L-NNA, with large conductance Ca2+-activated K+ channels playing a key role.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: